Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 115.18 billion as of November 5, 2025. Its market cap has decreased by -34.64% in one year.

Market Cap

115.18B

Enterprise Value

336.55B

Revenue

68.32B

Ranking

n/a

PE Ratio

n/a

Stock Price

594.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 115.18B, an increase of 3,521.52%. That is a compound annual growth rate of 12.78%.

Market Cap History

Date	Market Cap	% Change
Nov 5, 2025	115.18B	-11.93%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	86.90T
Celltrion	38.53T
ALTEOGEN	28.29T
SK Biopharmaceuticals	9.44T
Yuhan	8.71T
HLB Co., Ltd.	7.14T
Peptron	6.11T
Hanmi Pharm.	5.82T

Market Cap Rankings